With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices
With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices kdunleavy Tue, 02/06/2024 - 15:34
With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices kdunleavy Tue, 02/06/2024 - 15:34
Amid GLP-1 supply constraints, Lilly to prep for oral obesity market 'at risk' zbecker Tue, 02/06/2024 - 12:53
As Vertex gears up for next-gen CF treatment, Trikafta sales reach $8.9B thanks to label expansions kdunleavy Tue, 02/06/2024 - 10:45
Already rolling in diabetes and obesity, Eli Lilly touts tirzepatide's midstage MASH win aliu Tue, 02/06/2024 - 10:05
AstraZeneca brings its cell therapy ambitions to Maryland with $300M plant investment, 150 planned hires fkansteiner Tue, 02/06/2024 - 09:42
Incyte picks up full Monjuvi rights from partner MorphoSys for $25M zbecker Tue, 02/06/2024 - 08:58
Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains fkansteiner Tue, 02/06/2024 - 08:44
GSK details Blenrep combo data that could bring the multiple myeloma ADC back to life aliu Mon, 02/05/2024 - 16:28